Skip to content
Screener

Pre-Tax Income at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$6.75B+3.9%
Merck & Co. logo
Merck & Co.MRK
-$683M-114%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
-$632.79M-387%
Arcus Biosciences logo
Arcus BiosciencesRCUS
-$91M
HRO
HarrowHROW
-$17.27M-446%

Other financials

Income statement

See full
Operating income-$34.9M-20.1%
Net income-$33.7M-22.6%
EPS (diluted)-$0.50+9.1%

Balance sheet

See full
Cash & equivalents$84.8M+122%
Total debt$17.0M-7.9%
Total equity$107.2M-16.2%
Total assets$137.7M-11.4%

Cash flow

See full
Operating cash flow-$29.9M-28.0%
CapEx$102.0K-45.5%
Free cash flow-$30.0M-27.4%

Valuation

See full
Market cap$826.46M+87.8%
Enterprise value$758.65M+118%

Returns & leverage

See full
Return on equity-95.6%+222pp
Debt / equity0.2×0.0×
Current ratio7.1×-4.0×

Where this comes from

Reported directly by Aura Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.

The source filing: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-216808
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Interest income, including amortization and accretion income1,1901,594
Other income (expense)2(24)
Total other income1,1921,570
Loss before income taxes(33,674)(27,465)
Income tax provision, net(11)(18)
Net loss$(33,685)$(27,483)
Net loss per common share—basic and diluted$(0.50)$(0.55)
Weighted average common stock outstanding—basic and diluted67,447,57650,126,148

Item 1. Financial Statements.

FAQ

What is Aura Biosciences, Inc.'s pre-tax income?
Aura Biosciences, Inc. (AURA) reported pre-tax income of -$33.67M in Q1 2026.
How has Aura Biosciences, Inc.'s pre-tax income changed year-over-year?
Aura Biosciences, Inc.'s pre-tax income decreased by 22.6% year-over-year, from -$27.47M to -$33.67M.
What is the long-term trend for Aura Biosciences, Inc.'s pre-tax income?
Over 3 years (2022 to 2025), Aura Biosciences, Inc.'s pre-tax income has grown at a 21.8% compound annual growth rate (CAGR), from -$58.76M to -$106.08M.
What does pre-tax income mean?
Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.

Ask your AI about Aura Biosciences, Inc.'s pre-tax income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude